CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to IART

Picosulfate sodium, magnesium oxide, citric acid

Phase 3
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Bowel Preparation Before Colonoscopy

View Full Landscape
Drug Information

Target Indication

Bowel Preparation Before Colonoscopy

Clinical Trial

NCT01984008

Last updated: 6/26/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Source: FDA Orange Book
Drug Science
Mechanism of action & safety profile
Developer

IART

INTEGRA LIFESCIENCES HOLDINGS CORP

Surgical & Medical Instruments & Apparatus•North America•NASDAQ
Related Pipeline
Quiklean® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP)Phase 3

Bowel Preparation

NorLeu3-A(1-7) in a gel formulationPhase 2

Foot Ulcer, Diabetic

BioDFence G3 Placental Tissue MembranePhase 2

Prostate Cancer

View full pipeline
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.